Skip to main content
PreveCeutical Medical logo

PreveCeutical Medical — Investor Relations & Filings

Ticker · PREV ISIN · CA74143C1068 LEI · 96760001OJCSH5MXZ450 CSE Professional, scientific and technical activities
Open in API
Filings indexed 438 across all filing types
Latest filing 2025-05-01 Regulatory Filings
Country CA Canada
Listing CSE PREV

About PreveCeutical Medical

https://www.preveceutical.com/

PreveCeutical Medical Inc. is a health sciences company dedicated to the research and development of innovative options for preventive and curative therapies. The company specializes in utilizing organic and nature identical products, combining scientific rigor with natural sources to benefit health-conscious consumers. Its primary focus is on the preventive health sector, collaborating with partners to bring novel solutions to market.

Recent filings

Filing Released Lang Actions
Audited annual financial statements – English.pdf
Regulatory Filings
2025-05-01 English
News release - English.pdf
Capital/Financing Update Classification · 90% confidence The document is a news release announcing the closing of an initial tranche of a non-brokered private placement, detailing unit pricing, warrants, use of proceeds, and future tranche plans. This is clearly an update on the company’s fundraising and capital structure. Therefore, it should be classified as a Capital/Financing Update.
2025-04-28 English
News release - English.pdf
Regulatory Filings
2025-04-15 English
News release - English.pdf
Capital/Financing Update Classification · 92% confidence The document is a press release announcing a non-brokered private placement – details on units being offered, pricing, use of proceeds, hold period, and closing conditions. This is a direct update on the company’s financing activity, matching the "Capital/Financing Update" category.
2025-04-03 English
News release - English.pdf
Capital/Financing Update Classification · 90% confidence The document is a news release titled “PreveCeutical Announces Update to Private Placement” describing an extension to close a non-brokered private placement and detailing financing terms and regulatory approvals. It is clearly an update on company fundraising/financing activity rather than an earnings release, AGM material, or regulatory notice. Therefore, it falls under Capital/Financing Update (CAP).
2025-03-10 English
News release - English.pdf
Regulatory Filings Classification · 82% confidence The document is a corporate news release (“For Immediate Release”) announcing a research program to develop a Sol-Gel N2B platform for Parkinson’s Disease. It contains forward-looking statements, CEO comments, and general corporate information. It is not an earnings announcement, financial report, regulatory filing like a 10-K/10-Q, proxy statement, share issuance or delisting notice, or any other defined category. Therefore, it falls into the fallback category for miscellaneous regulatory announcements.
2025-02-10 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.